April 2008 - IOZK

Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma

2008-04-24/in Dendritic Cells, Hyperthermia, International Publications, Malignant Melanoma /von 2008-04-24 / Vaccine 2008 Jun;26(27-28):3540-9

Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia

2008-04-21/in Chronic Leukemia, International Publications /von 2008-04-21 / J. Leukoc. Biol. 2008 Jul;84(1):319-25

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model

2008-04-15/in Glioblastoma, International Publications /von 2008-04-15 / Int. J. Cancer 2008 Apr;122(8):1794-802

Cell- and peptide-based immunotherapeutic approaches for glioma

2008-04-09/in Dendritic Cells, Glioblastoma, International Publications /von 2008-04-09 / Trends Mol Med 2008 May;14(5):228-35

Reengineering dendritic cell-based anti-cancer vaccines

2008-04-01/in Breast Cancer, International Publications /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:256-76

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

2008-04-01/in HIV/AIDS, International Publications /von 2008-04-01 / J. Clin. Invest. 2008 Apr;118(4):1427-36

An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins

2008-04-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):777-89

Strategies and challenges in eliciting immunity to melanoma

2008-04-01/in International Publications, Malignant Melanoma /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:28-42

Cancer vaccines for established cancer: how to make them better?

2008-04-01/in International Publications, Malignant Melanoma /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:242-55

Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cells

2008-04-01/in International Publications, Malignant Melanoma /von 2008-04-01 / Cancer Biother. Radiopharm. 2008 Apr;23(2):214-21